WO1995002371A2 - Rectal and rectosigmoid cancer tunnelling umbrella - Google Patents

Rectal and rectosigmoid cancer tunnelling umbrella Download PDF

Info

Publication number
WO1995002371A2
WO1995002371A2 PCT/GB1994/001537 GB9401537W WO9502371A2 WO 1995002371 A2 WO1995002371 A2 WO 1995002371A2 GB 9401537 W GB9401537 W GB 9401537W WO 9502371 A2 WO9502371 A2 WO 9502371A2
Authority
WO
WIPO (PCT)
Prior art keywords
umbrella
cutting
diathermic
spokes
tip
Prior art date
Application number
PCT/GB1994/001537
Other languages
French (fr)
Other versions
WO1995002371A3 (en
Inventor
Aws Shakir Mustafa Salim
Original Assignee
Aws Shakir Mustafa Salim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aws Shakir Mustafa Salim filed Critical Aws Shakir Mustafa Salim
Priority to AU71910/94A priority Critical patent/AU7191094A/en
Publication of WO1995002371A2 publication Critical patent/WO1995002371A2/en
Publication of WO1995002371A3 publication Critical patent/WO1995002371A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/320725Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320016Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/148Probes or electrodes therefor having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means

Definitions

  • the present invention relates to a diathermy umbrella device suitable for use in overcoming the emergency situation of large bowel obstruction caused by rectal or rectosigmoid tumours including carcinoma.
  • the system employs diathermy cutting for tunnelling through and coring out the cancerous growth. Decompression of the bowel by this method avoids emergency surgery with its high morbidity and mortality rates and enables an elective operation to be carried out at a later date in a patient who has been properly investigated and prepared with a view to definitive surgery during the same hospital admission.
  • the present invention uses a diathermy umbrella device delivered endoscopically, using rigid or fibreoptic instruments, to the rectal or rectosigmoid part obstructed by tumours including benign and malignant neoplasms such as cancer.
  • the device may be a single use disposable or reusable instrument.
  • the basic principle of the diathermy current with regards to the invention is that of heating the device's tip and umbrellas (spokes and their connecting webs and or strings and rods) by high frequency electric current passing through their heating elements thus providing a cutting and/or coagulating effect.
  • the present invention provides a diathermy tunnelling umbrella device suitable for use via the biopsy channel of an endoscope or through a proctoscope or a rigid sigmoidoscope and having remotely operable first and second opposed collapsible umbrella means with a diathermic distal end cutting and coagulating tip, a plurality of spaced apart diathermic cutting and coagulating spokes of the first umbrella means extending rearwardly from said tip towards the second umbrella means which has a plurality of spaced apart diathermic cutting and coagulating spokes extending forwardly towards said first umbrella means, whereby in use the device tip is advanced by diathermic cutting therewith into a growth with the umbrella means in substantially collapsed condition, at least one of said umbrella means is opened out by diathermic cutting of the spokes thereof generally radially outwardly into the growth, and the umbrella means manipulated by rotation and/or axially to and fro movements for further diathermic cutting into said growth.
  • the spokes are interconnected by web means and/or diathermic cutting nd coagulating flexible elongate connectors.
  • the electric current provides electrocoagulation at both the tip and umbrella spokes and their connecting means to provide haemostasis if necessary.
  • this current may be unipolar or bipolar.
  • the tip of the umbrella device can tunnel through the growth using diathermy current, and once it has advanc-d for some distance, the proximal and/or distal umbrella is(are) opened up and their spokes used to core out the centre portion of the growth by forward or backward cutting manoeuvres with rotation to establish a complete tunnel though the tumour which relieves the emergency situation.
  • This invention was initially developed in experimental animals and later successfully applied to the clinical situation.
  • the umbrella device may be manufactured in sizes suitable for use through the rigid proctoscope and sigmoidscope or the flexible scopes.
  • the device can also be manufactured in sizes to suit veterinary uses.
  • the present invention may be made in total or in part from metals such as steel, silver, aluminium, titanium etc, or alloys such as stainless steel. Certain parts may be made of plastics, silicones and/or rubber.
  • an antibiotic or antiseptic may be incorporated into any or all the parts of the device.
  • Fig 1 is a general view of one embodiment a diathermy tunnelling umbrella device of the invention
  • Fig.2 is a schematic representation of a suitable remote control opening means for one of the umbrellas of the device of Fig.l;
  • Fig.3 shows some different spoke end configurations
  • Fig.4 shows some spoke edge configurations
  • Fig.5 shows some spoke surface formations
  • Patients who present with absolute constipation and abdominal distension produced by rectal or rectosigmoidal cancer are suitable for endoscopic tunnelling carried out as an emergency. Distension caused by faecal impaction should be excluded by two successive phosphate enemas one hour apart. Patients who present with peritonitis should proceed to a full laparotomy; otherwise endoscopic tunnelling can be offered to all emergency cases with large bowel obstruction as defined above.
  • endoscopic tunnelling can be offered to all emergency cases with large bowel obstruction as defined above.
  • a suitable intravenous antibiotic is given as prophylaxis then endoscopic examination using the rigid proctoscope, rigid sigmoidoscope and/or fibreoptic sigmoidoscope or colonoscope of the rectosigmoid lesion is carried out while the patient is under sedation by intravenous narcotic analgesics with or without benzodiazepines and midazolam.
  • the procedure may also be carried out under general anaesthesic if this is indicated or preferable and in the left lateral position.
  • the obstructive lesion is located under direct vision and biopsied if necessary.
  • the umbrella device is then passed through a rigid scope or the biopsy channel of a fibreoptic endoscope (not shown) and placed against the central portion of the lesion.
  • the current is switched on and the tip 2 of umbrella 1 pushed into the lesion.
  • Approximately one half to one centimetre lengths of the growth are cored out using the proximal and/or distal umbrellas 3, 4 by means of a process of opening up the umbrella 3, 4 and splaying out radially outwardly the main spokes 5 of the umbrella 3, 4 using the remote control operating handle means 7, 8 at the proximal end 9 of a respective elongate Bowden cable-type remote control operating link 10 and coring out
  • the main spokes 5 of the umbrellas 3, 4 are supported by a combination of links levers connected to a sliding collar in substantially similar manner to that used in conventional umbrellas and parasols used to provide shelter against sun or rain, and are not shown in detail herein) .
  • the simplest method is that of going through the growth with the tip 2 using cutting and coagulating current and coring off by the distal umbrella 4, twisting it every now and then or rotating it coupled with forward and backward movements to cut off tissues. Then when a full tunnel has been cored out, this is enlarged by opening further the distal umbrella 4 and withdrawing it, a procedure preferably supplemented by a rotating manoeuvre to extract the tissue that has been cut away. The procedure is continued until the obstruction is overcome and gas and faecal matter begin escaping. Obviously bleeding points can be electrocoagulated to achieve hae ostasis using the tip of the instrument or either of the umbrellas. The endoscope and umbrella device are then taken out.
  • a phosphate enema is administered. Thereafter no oral intake restrictions are required and the patient is allowed up and about. The procedure of coring may be repeated the following day and 2 to 4 days later to ensure a suitable and adequate passage exists through the tumour. The patient is meanwhile prepared and investigated for definitive surgery to be carried out a few days later and during the same hospital admission. The investigations can now include colonoscopic and barium enema examinations through the tunnel in the growth.
  • Endoscopic tunnelling has been found during preliminary clinical investigations to be a simple, safe and effective procedure which offers advantages in the emergency management of large bowel obstruction caused by rectal or rectosigmoid tumours be they benign or malignant, particularly in the elderly and the very seriously ill patients.
  • the procedure overcomes the obstruction thus directing efforts to improving the general condition of the patient.
  • the technique is associated with no complications and permits patients to be properly investigated and prepared for definitive surgery a few days later and during the same hospital admission.
  • Endoscopic tunnelling incurs the following gains in the overall management of emergency cases presenting with colonic obstruction caused by rectal or rectosigmoid tumours including cancer:
  • the present invention provides a tunnelling umbrella for use to relieve large bowel obstruction caused by rectal or rectosigmoid tumours, including carcinoma.
  • the device is introduced to the site of the blockage via the biopsy channel of a flexible scope or through the lumen of a rigid proctoscope or sigmoidoscope and consists of an externally controllable cutting and coagulating apparatus containing:
  • the device In operation, the device is caused to enter the blockage by pushing the diathermic tip partially into it, with the umbrellas in the collapsed state. Diathermy currents are then applied to enable the tip to be advanced to the desired depth and to be appropriately positioned.
  • the umbrellas are now progressively opened with rotation and backward/forward movement to core out a passageway through the blockage. When the passageway is sufficiently large, the device is retracted from the bowel with the upper (distal) umbrella still open allowing excised tissue to be removed. The procedure can be repeated the following day and 2 to 4 days later.
  • the tip and umbrellas are designed to deliver diathermy cutting and/or coagulating currents. Both monopolar and bipolar diathermy currents may be employed.
  • the device may be made of sizes suitable for use through the biopsy channel of flexible scopes (sigmoidoscope, colonoscope) or through the lumen of rigid scopes (proctoscope, sigmoidoscope) or for veterinary usage.
  • One or all parts of the catheter may be made of metals such as steel, silver, aluminium, titanium etc or their alloys such as stainless steel.
  • One or more parts of the device may be made of plastic, rubber, silicones or their combinations.
  • the most prefered substances to be employed are Teflon, Dacron, (Trade Names) latex, polyvinylchloride and biocompatible silicones.
  • the materials and substances employed in the making of the tunnelling apparatus may be silver-impregnated or incorporate a silver-impregnated protective sheath.
  • bacterial resistant materials may be advantageously used in the manufacturing of all or part of the device. This includes the use of antibiotic bonded apparatus/device material.
  • the umbrella device may be manufactured for single use (disposable) or several uses (re-useable) after sterilization by ethylene oxide gas or autoclaving.
  • the overall length of the tunnelling umbrella head is generally in the range from 100mm to 2000mm, preferably 1500mm to 1600mm for use with the fibreoptic flexible scope (sigmoidoscope, colonoscope) and 100mm to 600mm for use with the rigid scopes (proctoscope, sigmoidoscope) .
  • the outer diameter of the device's catheter ranges from 1.5mm to 30mm, preferably 1.8mm to 2.8mm for use with a fibreoptic scope and 2mm to 8mm for use with a rigid scope.
  • the outer sheath of the device's catheter may be made as a tube sheath type or coil sheath type.
  • the tube sheath can be made to provide a highly flexible catheter sheath.
  • the tip of the device is generally a solid stiff structure, but, if desired, it can be made more or less flexible.
  • the overall length is preferably from 2mm to 30mm, most preferably 5mm to 10mm.
  • the tip may be in the shape of a needle or have a round bodied end.
  • the needle can be pointed or bevelled having a diagonal slar- of an angle ranging from 10° to 80°, preferably 30 c a 45°.
  • the body of the device's tip may be cylindrical, faceted having 3 to 10 surfaces, serrated, saw-toothed or uneven with a roughened surface.
  • the tip may be conical or frusto-conical having a base wider and larger than the end.
  • the tip could also be in the shape of a corkscrew to facilitate tunnelling and a ⁇ such could have from 1 to 15 turns.
  • the handle of the device is desirably formed and arranged so as to be substantially ergonomic and provide good grip and handling characteristics that enable the tip and the two umbrellas (with their electrical functions) to be independently and effectively applied.
  • the handle generally carries a remote control mechanism for each of the two umbrellas that can be independently operated and may also carry the electrical connections for the active electrode besides the necessary switches to switch the electrical current on or off, regulate its intensity and determine whether it is cutting or coagulating.
  • the handle can range from 2cm to 20cm in length and 0.5cm to 10cm in width. It may be in the form of a disc, cylinder, sphere, triangle, square, rectangle or any other geometrical or non-geometrical shape. It can be in one or more parts e.g.
  • the handle can be made in two halves.
  • it can incorporate a sliding forward and backward movement mechanism.
  • the handle may also include hinges. When made of many parts, each or all may be fixed or allow the movement of one part onto the other.
  • the handle may incorporate from one to five finger accommodating bars, ridges, grooves, holes, rings or circular bonds. These may also be provided separately for each of the two umbrella controlling mechanisms if such mechanisms are located outside the main body of the handle. Any part of the handle may be solid or hollowed.
  • the umbrella operating mechanisms are preferably two independent means that allow each umbrella to be operated individually.
  • Such mechanisms may be in the form of knobs, handles, rings, bars, ridges, switches, levers, buttons or any other suitable design that enables manual opening and closing of each of the two umbrellas separately.
  • the handle may incorporate two pistons that can be independently pushed backward and forward to open or close each of the umbrellas. These pistons may have a ring shaped, spherical, rounded, circular, discoid, T-shaped or any other suitable shaped handle for operating and remote controlling the umbrellas that may be fitted onto the rear or side of the handle.
  • the handle can carry the electrical connections and/or deliver the electrical current from the active electrode to the two umbrellas and tip.
  • the handle may incorporate one to ten electixcal plugs or sockets which may be flush with the surface or project above it. These connecting points may be placed anywhere on the handle.
  • all electric connections may be removed from the handle and incorporated directly into the main body of the catheter.
  • Each of the two umbrellas of the tunnelling device is preferably made from up of 2 to 12 spokes.
  • the length of each spoke generally ranges from 3mm to 50mm, preferably 5mm to 15mm.
  • the diameter, width or cross section generally ranges from 0.1mm to 5mm.
  • the spokes are connected to the central axial support "pole" by hinges or welded onto it at on end. Alternatively the spokes may be cut out of an outer catheter sleeve which surrounds the central pole. The spokes open up radially around a central pole by mechanical displacement.
  • the spokes may be in the form of wires, blades or bars.
  • the bars may be triangular, square, rectangular or of other polygonal section having from 5 to 12 surfaces in cross section or could have a rounded section.
  • the wires, bars and blades may have serrated, roughened, spikey, notched, grater-like or saw-toothed surfaces to enable cutting into tissues while providing a firm grip or hold onto them.
  • the wires may be spring coils or rods.
  • the free end of each spoke may be pointed, bevelled, rounded, knob-shaped, L-shaped, T-shaped, spiral or any other suitable design to enable a better tissue grip for cutting and coagulating to be achieved.
  • Each umbrella may be made of the same type of spokes, whose surfaces may be similar or a combination of the types described above, or use different types of spokes with similar or different surfaces.
  • the lengths of the spokes of each umbrella may be the same or different. Similarily, the two umbrellas may be similar or different with regards to size, length, number and shape of spokes, including their lengths and surfaces.
  • each umbrella may be connected together by one or more e.g. up to five webs, chains or other more or less flexible connectors.
  • the outer diameter of the collapsed umbrella is preferably from 1.5mm to 10mm, most preferably 1.5mm to 2.8mm for use with the fibreoptic flexible scopes.
  • the diameter of umbrella when opened up is generally from 10mm to 40mm.
  • All the spokes within each umbrella can be arranged to deliver electrocoagulating and cutting diathermy currents.
  • each umbrella is individually and separately operable by remote control means built into the handle or attached to it.
  • the device is delivered to the site of blockage under direct vision and with both umbrellas in the closed collapsed shape.
  • the tip is placed in direct contact with the lesion and the current is switched on.
  • the tip is advanced into the lesion; then the distal umbrella is slightly opened while the cutting current is switched on to enable the spokes to cut into the lesion; and the device is next rotated to core out some of the lesion. It is desirable that the whole coring out procedure be carried out strictly under direct vision.
  • the tip of the device should not be pushed too much into the lesion at any one time, nor should the radially outward coring out be too generous.
  • Sufficient coring out should desiarably though be carried out to enable correct guidance of the tip more deeply into the lesion as required.
  • the tip is pushed beyond the lesion to enable the distal umbrella to be opened up beyond the lesion, then the device is withdrawn with the cutting current still on to core out more of the lesion.
  • the two umbrellas may be simultaneously or successively used to effect the most desirable coring out of the lesion which creates sufficient passageway that unblocks the rectum or rectosigmoid region.
  • diathermy operates by producing an alternating current with wavelengths generally in the radio frequency range.
  • This current passes through the patient's tissues from the active electrode, which may be of various shapes,to the indifferent or dispersive electrode, which is usually a metal or foil plate approximately 15 X 15cm in size.
  • the active electrode which may be of various shapes
  • the indifferent or dispersive electrode which is usually a metal or foil plate approximately 15 X 15cm in size.
  • the indifferent electrode has a large contact area and therefore heating is reduced to a minimum and is dissipated rapidly.
  • the active electrode being small will concentrate heat in the tissues adjacent to it.
  • the current intensity determines whether a coagulating, fulguration or electro- sectioning is produced.
  • the circuit of the diathermy machine being generally similar to that of a simple radio transmitter will generally oscillate at a frequency between 400kHz
  • valve oscillators of a frequency range of up to 3MHz may be used. This can be in the form of two circuits: with a cutting circuit operated by a valve oscillator and the coagulating circuit operated by a spark-gap oscillator. Diathermy generators of power outputs up to 1 kW may conveniently be employed. The use of transistors as oscillators rather than valves is more advantageous.
  • the quality of coagulation or cutting generally depends on the wave form presented by the diathermy machine, with a smooth sine wave giving the desired cutting while an interrupted burst of current provides the desired coagulation depending on the frequency of these bursts and the length of the gap between each burst.
  • the spark-gap machine gives bursts of damped oscillation of a frequency of approximately 10kHz. When this interuption of current is superimposed on the sine wave oscillation, the coagulation quality is comparable to that of the spark-gap machine.
  • the amplitude of each wave should be increased in portion to the length of each burst of current. Thus the doubled circuit may be dispensed with.
  • Blending the current may be provided by a twin-circuit diathermy where the blender switch brings both circ ..ts into action at the same time with the result that the active electrode produces a cutting effect as well as a coagulating effect as it passes through the tissues.
  • a solid state transistorised diathermy machine can be used to provide a blended current from a single circuit by taking the setting halfway between the pure sine wave for cutting and repeated short bursts for coagulation. This provides the advantage of subjecting the patient to only the normal power output of a single circuit.
  • electro-sectioning can be provided by cutting with a valve or transistorised oscillator to ensure minimal surrounding tissue damage or cutting with a blended current if moderate degrees of surrounding coagulation is desirable.
  • the diathermy machine should normally be earthed to the floor to avoid build up of electrical potential which could discharge in the form of a spark of static electricity. It may be advantageous to monitor the contact of the plate electrode to patient by measuring the potential difference between the in; z and output leads.
  • the overall power output of the diathermy machine is preferably restricted to from 400 to 500 kW.
  • the diathermy generator may conveniently be provided by valve oscillating machines, double - circuit spark and valve machines, transistorised solid state diathermies and spark-gap generators.
  • a foot pedal switch or finger switch may be used to activate the diathermy set, i.e. activating the operating electrode to start the diathermy.
  • its cable is preferably designed to have an internal circuit so that if any point between the plate and the diathermy machine is disconnected then an alarm will sound which should also inactivate the circuit of the machine. This may not be necessary with earth-free circuits since the diathermy will be non-operated when the patient is not in contact with the indifferent electrode. Thus, earth-free circuits may also be used for the purposes of the present invention.
  • the electric connections to the diathermy machine may be placed on any part of the handle.
  • the active electrode socket may be designed in any convenient way to enable the current to flow from the diathermy machine to the catheter tip and both umbrellas. This socket transmits the electric current from the machine directly to the tunnelling device. It may be flush flat with the handle surface or project above it.
  • the active electrode may be plugged in, screwed in, clipped-on or fitted into the socket in any convenient way through one or more points of contact.
  • the handle may have a finger switch to activate the diathermy set. Conversely this may be provided by a foot pedal.
  • the indifferent electrode plate is preferably stuck, strapped or attached in any way onto the patients lower limb, but other sites may also be used.
  • the tunnelling device is introduced into the rectum or rectosigmoid region and placed in direct contact with the lesion or tumour.
  • the active electrode is connected to the device then the diathermy machine is switched on.
  • the coagulating and cutting currents are generally set in the range from 20 to 90 A, preferably 30 to 60 A. During use the diathermy machine makes a noise which can be clearly heard to indicate it is working and the current is flowing. The coagulating and cutting currents are used as already described. Repeated sessions of tunnelling may be necessary to achieve the desired coring and tunnelling.
  • remote control operations handle mechanisms may be used including: systems with first and second relatively displacable finger rings or other finger engagement formations which may simply be relatively displacable longitudinally of the device, so as to provide a more or less direct longitudinal compression of the basket resulting in radial expansion, or may be relatively displacable in other dimensions e.g. by compressing or pulling laterally towards each other, conveniently against a return force exerted by resilient biasing means, spaced apart finger engagement portions and use one or more of links, levers, gears and other well known mechanisms for converting relative displacement into a suitable form for transmission to the basket members.
  • hydraulic circuit means and/or electromechanical device may be used for transmitting required control movements to the basket in generally known maner.
  • the diathermic cutting and coagulating power supply control means are also provided on the handle means but this is not essential and they may be formed and arranged so as to be operable remotely from the handle means e.g. via a foot operated interface.

Abstract

The present invention provides a diathermy tunnelling umbrella device usable via the biopsy channel of an endoscope or through a proctoscope or a rigid sigmoidoscope. The device has remotely operable first and second opposed collapsible umbrella means with a diathermic distal end cutting and coagulating tip. A plurality of spaced apart diathermic cutting and coagulating spokes of the first umbrella means extend rearwardly from the tip towards the second umbrella means. The second umbrella means has a plurality of spaced apart diathermic cutting and coagulating spokes extending forwardly towards the first umbrella means. In use the device tip is advanced by diathermic cutting therewith into a growth with the umbrella means in substantially collapsed condition, at least one of the umbrella means is opened out by diathermic cutting of the spokes thereof generally radially outwardly into the growth, and the umbrella means manipulated by rotation and/or upward and downward movements for further diathermic cutting into said growth.

Description

RECTAL AND RECTOSIGMOID CANCER TUNNELLING UMBRELLA
The present invention relates to a diathermy umbrella device suitable for use in overcoming the emergency situation of large bowel obstruction caused by rectal or rectosigmoid tumours including carcinoma. The system employs diathermy cutting for tunnelling through and coring out the cancerous growth. Decompression of the bowel by this method avoids emergency surgery with its high morbidity and mortality rates and enables an elective operation to be carried out at a later date in a patient who has been properly investigated and prepared with a view to definitive surgery during the same hospital admission.
Fashioning a colostomy for the emergency presentation of large bowel obstruction caused by rectal or rectosigmoidal cancer does not represent the appropriate surgical approach necessary for dealing with the distended bowel and its plethoric part. Conversely, resectional surgery may be very challenging for the emergency surgeon who may be of limited experience in this type of surgery. It is now widely accepted that complete large bowel obstruction may lead to systemic problems thus producing a seriously ill patient which renders the management of the obstructed bowel only one facet of the treatment of a patient with multi-system failure. Consequently, overcoming the obstruction in a simple expeditious way which is least burdening to the patient represents a primary
Figure imgf000003_0001
in the management of patient cases with large bowel obstruction. This would allow the valuable time n' pessary to improve the patient's general condition and „hen to investigate him/her with the potential for offering definitive surgery a few days later and during the same hospital admission. It is an object of the present invention to avoid or minimize one or more of the above disadvantages and problems.
The present invention uses a diathermy umbrella device delivered endoscopically, using rigid or fibreoptic instruments, to the rectal or rectosigmoid part obstructed by tumours including benign and malignant neoplasms such as cancer. The device may be a single use disposable or reusable instrument. The basic principle of the diathermy current with regards to the invention is that of heating the device's tip and umbrellas (spokes and their connecting webs and or strings and rods) by high frequency electric current passing through their heating elements thus providing a cutting and/or coagulating effect.
The present invention provides a diathermy tunnelling umbrella device suitable for use via the biopsy channel of an endoscope or through a proctoscope or a rigid sigmoidoscope and having remotely operable first and second opposed collapsible umbrella means with a diathermic distal end cutting and coagulating tip, a plurality of spaced apart diathermic cutting and coagulating spokes of the first umbrella means extending rearwardly from said tip towards the second umbrella means which has a plurality of spaced apart diathermic cutting and coagulating spokes extending forwardly towards said first umbrella means, whereby in use the device tip is advanced by diathermic cutting therewith into a growth with the umbrella means in substantially collapsed condition, at least one of said umbrella means is opened out by diathermic cutting of the spokes thereof generally radially outwardly into the growth, and the umbrella means manipulated by rotation and/or axially to and fro movements for further diathermic cutting into said growth.
Advantageously the spokes are interconnected by web means and/or diathermic cutting nd coagulating flexible elongate connectors. Advantage; ly, the electric current provides electrocoagulation at both the tip and umbrella spokes and their connecting means to provide haemostasis if necessary. In addition this current may be unipolar or bipolar.
The tip of the umbrella device can tunnel through the growth using diathermy current, and once it has advanc-d for some distance, the proximal and/or distal umbrella is(are) opened up and their spokes used to core out the centre portion of the growth by forward or backward cutting manoeuvres with rotation to establish a complete tunnel though the tumour which relieves the emergency situation. This invention was initially developed in experimental animals and later successfully applied to the clinical situation.
The umbrella device may be manufactured in sizes suitable for use through the rigid proctoscope and sigmoidscope or the flexible scopes. The device can also be manufactured in sizes to suit veterinary uses. The present invention may be made in total or in part from metals such as steel, silver, aluminium, titanium etc, or alloys such as stainless steel. Certain parts may be made of plastics, silicones and/or rubber. Advantageously an antibiotic or antiseptic may be incorporated into any or all the parts of the device.
Further preferred features and advantages of the invention will appear from the following detailed description given by way of example of the use of an umbrella device of the invention, with reference to the accompanying drawings in which:
Fig 1 is a general view of one embodiment a diathermy tunnelling umbrella device of the invention;
Fig.2 is a schematic representation of a suitable remote control opening means for one of the umbrellas of the device of Fig.l;
Fig.3 shows some different spoke end configurations;
Fig.4 shows some spoke edge configurations; and
Fig.5 shows some spoke surface formations
Patients who present with absolute constipation and abdominal distension produced by rectal or rectosigmoidal cancer are suitable for endoscopic tunnelling carried out as an emergency. Distension caused by faecal impaction should be excluded by two successive phosphate enemas one hour apart. Patients who present with peritonitis should proceed to a full laparotomy; otherwise endoscopic tunnelling can be offered to all emergency cases with large bowel obstruction as defined above. After physical examination and appropriate investigations including plain abdominal X-Rays, Sigmoidoscopic examination with or without biopsies and emergency barium enema (for diagnostic and therapeutic purposes) , the patient is fasted and nasogastric aspiration with intravenous hydration commenced. A suitable intravenous antibiotic is given as prophylaxis then endoscopic examination using the rigid proctoscope, rigid sigmoidoscope and/or fibreoptic sigmoidoscope or colonoscope of the rectosigmoid lesion is carried out while the patient is under sedation by intravenous narcotic analgesics with or without benzodiazepines and midazolam. The procedure may also be carried out under general anaesthesic if this is indicated or preferable and in the left lateral position. The obstructive lesion is located under direct vision and biopsied if necessary. The umbrella device is then passed through a rigid scope or the biopsy channel of a fibreoptic endoscope (not shown) and placed against the central portion of the lesion. The current is switched on and the tip 2 of umbrella 1 pushed into the lesion. Approximately one half to one centimetre lengths of the growth are cored out using the proximal and/or distal umbrellas 3, 4 by means of a process of opening up the umbrella 3, 4 and splaying out radially outwardly the main spokes 5 of the umbrella 3, 4 using the remote control operating handle means 7, 8 at the proximal end 9 of a respective elongate Bowden cable-type remote control operating link 10 and coring out (The main spokes 5 of the umbrellas 3, 4 are supported by a combination of links levers connected to a sliding collar in substantially similar manner to that used in conventional umbrellas and parasols used to provide shelter against sun or rain, and are not shown in detail herein) . The simplest method is that of going through the growth with the tip 2 using cutting and coagulating current and coring off by the distal umbrella 4, twisting it every now and then or rotating it coupled with forward and backward movements to cut off tissues. Then when a full tunnel has been cored out, this is enlarged by opening further the distal umbrella 4 and withdrawing it, a procedure preferably supplemented by a rotating manoeuvre to extract the tissue that has been cut away. The procedure is continued until the obstruction is overcome and gas and faecal matter begin escaping. Obviously bleeding points can be electrocoagulated to achieve hae ostasis using the tip of the instrument or either of the umbrellas. The endoscope and umbrella device are then taken out. When spontaneous passage of gas and faeces has ceased, a phosphate enema is administered. Thereafter no oral intake restrictions are required and the patient is allowed up and about. The procedure of coring may be repeated the following day and 2 to 4 days later to ensure a suitable and adequate passage exists through the tumour. The patient is meanwhile prepared and investigated for definitive surgery to be carried out a few days later and during the same hospital admission. The investigations can now include colonoscopic and barium enema examinations through the tunnel in the growth.
Endoscopic tunnelling has been found during preliminary clinical investigations to be a simple, safe and effective procedure which offers advantages in the emergency management of large bowel obstruction caused by rectal or rectosigmoid tumours be they benign or malignant, particularly in the elderly and the very seriously ill patients. The procedure overcomes the obstruction thus directing efforts to improving the general condition of the patient. The technique is associated with no complications and permits patients to be properly investigated and prepared for definitive surgery a few days later and during the same hospital admission. Endoscopic tunnelling incurs the following gains in the overall management of emergency cases presenting with colonic obstruction caused by rectal or rectosigmoid tumours including cancer:
1. avoiding emergency surgery on an obstructed unprepared bowel 2. avoiding an operation by a person of limited experience
3. avoiding surgery on patients who are too ill on initial presentation
4. gaining valuable time properly to investigate the cause of the obstruction and for planning of the correct surgical approach
5. allowing carrying out of a definitive procedure during the same hospital admission
6. adequate preparation of the patient for the definitive surgery.
7. shortening the overall hospital stay thus reducing costs and helping to ease the bed pressure situation.
The present invention provides a tunnelling umbrella for use to relieve large bowel obstruction caused by rectal or rectosigmoid tumours, including carcinoma. The device is introduced to the site of the blockage via the biopsy channel of a flexible scope or through the lumen of a rigid proctoscope or sigmoidoscope and consists of an externally controllable cutting and coagulating apparatus containing:
1. a diathermic tip
2. two sets of diathermic spokes in the form of back-to-back umbrellas whic;i can be independently expanded or contracted to provide a variable cutting/coagulating radius.
In operation, the device is caused to enter the blockage by pushing the diathermic tip partially into it, with the umbrellas in the collapsed state. Diathermy currents are then applied to enable the tip to be advanced to the desired depth and to be appropriately positioned. The umbrellas are now progressively opened with rotation and backward/forward movement to core out a passageway through the blockage. When the passageway is sufficiently large, the device is retracted from the bowel with the upper (distal) umbrella still open allowing excised tissue to be removed. The procedure can be repeated the following day and 2 to 4 days later. The tip and umbrellas are designed to deliver diathermy cutting and/or coagulating currents. Both monopolar and bipolar diathermy currents may be employed.
The device may be made of sizes suitable for use through the biopsy channel of flexible scopes (sigmoidoscope, colonoscope) or through the lumen of rigid scopes (proctoscope, sigmoidoscope) or for veterinary usage.
One or all parts of the catheter may be made of metals such as steel, silver, aluminium, titanium etc or their alloys such as stainless steel. One or more parts of the device may be made of plastic, rubber, silicones or their combinations. The most prefered substances to be employed are Teflon, Dacron, (Trade Names) latex, polyvinylchloride and biocompatible silicones. The materials and substances employed in the making of the tunnelling apparatus may be silver-impregnated or incorporate a silver-impregnated protective sheath. Similarly, bacterial resistant materials may be advantageously used in the manufacturing of all or part of the device. This includes the use of antibiotic bonded apparatus/device material.
The umbrella device may be manufactured for single use (disposable) or several uses (re-useable) after sterilization by ethylene oxide gas or autoclaving.
The overall length of the tunnelling umbrella head is generally in the range from 100mm to 2000mm, preferably 1500mm to 1600mm for use with the fibreoptic flexible scope (sigmoidoscope, colonoscope) and 100mm to 600mm for use with the rigid scopes (proctoscope, sigmoidoscope) .
The outer diameter of the device's catheter ranges from 1.5mm to 30mm, preferably 1.8mm to 2.8mm for use with a fibreoptic scope and 2mm to 8mm for use with a rigid scope.
The outer sheath of the device's catheter may be made as a tube sheath type or coil sheath type. The tube sheath can be made to provide a highly flexible catheter sheath.
The tip of the device is generally a solid stiff structure, but, if desired, it can be made more or less flexible. The overall length is preferably from 2mm to 30mm, most preferably 5mm to 10mm. The tip may be in the shape of a needle or have a round bodied end. The needle can be pointed or bevelled having a diagonal slar- of an angle ranging from 10° to 80°, preferably 30c a 45°.
The body of the device's tip may be cylindrical, faceted having 3 to 10 surfaces, serrated, saw-toothed or uneven with a roughened surface. Advantageously, the tip may be conical or frusto-conical having a base wider and larger than the end. The tip could also be in the shape of a corkscrew to facilitate tunnelling and aε such could have from 1 to 15 turns.
The handle of the device is desirably formed and arranged so as to be substantially ergonomic and provide good grip and handling characteristics that enable the tip and the two umbrellas (with their electrical functions) to be independently and effectively applied. The handle generally carries a remote control mechanism for each of the two umbrellas that can be independently operated and may also carry the electrical connections for the active electrode besides the necessary switches to switch the electrical current on or off, regulate its intensity and determine whether it is cutting or coagulating. The handle can range from 2cm to 20cm in length and 0.5cm to 10cm in width. It may be in the form of a disc, cylinder, sphere, triangle, square, rectangle or any other geometrical or non-geometrical shape. It can be in one or more parts e.g. it can be made in two halves. Advantageously, it can incorporate a sliding forward and backward movement mechanism. The handle may also include hinges. When made of many parts, each or all may be fixed or allow the movement of one part onto the other. The handle may incorporate from one to five finger accommodating bars, ridges, grooves, holes, rings or circular bonds. These may also be provided separately for each of the two umbrella controlling mechanisms if such mechanisms are located outside the main body of the handle. Any part of the handle may be solid or hollowed.
The umbrella operating mechanisms are preferably two independent means that allow each umbrella to be operated individually. Such mechanisms may be in the form of knobs, handles, rings, bars, ridges, switches, levers, buttons or any other suitable design that enables manual opening and closing of each of the two umbrellas separately. Optionally, the handle may incorporate two pistons that can be independently pushed backward and forward to open or close each of the umbrellas. These pistons may have a ring shaped, spherical, rounded, circular, discoid, T-shaped or any other suitable shaped handle for operating and remote controlling the umbrellas that may be fitted onto the rear or side of the handle.
Besides mounting the umbrellas' operating mechanisms, the handle can carry the electrical connections and/or deliver the electrical current from the active electrode to the two umbrellas and tip. As such, the handle may incorporate one to ten electixcal plugs or sockets which may be flush with the surface or project above it. These connecting points may be placed anywhere on the handle. Optionally all electric connections may be removed from the handle and incorporated directly into the main body of the catheter.
Each of the two umbrellas of the tunnelling device is preferably made from up of 2 to 12 spokes. The length of each spoke generally ranges from 3mm to 50mm, preferably 5mm to 15mm. The diameter, width or cross section generally ranges from 0.1mm to 5mm. The spokes are connected to the central axial support "pole" by hinges or welded onto it at on end. Alternatively the spokes may be cut out of an outer catheter sleeve which surrounds the central pole. The spokes open up radially around a central pole by mechanical displacement.
The spokes may be in the form of wires, blades or bars. The bars may be triangular, square, rectangular or of other polygonal section having from 5 to 12 surfaces in cross section or could have a rounded section. The wires, bars and blades may have serrated, roughened, spikey, notched, grater-like or saw-toothed surfaces to enable cutting into tissues while providing a firm grip or hold onto them. The wires may be spring coils or rods. The free end of each spoke may be pointed, bevelled, rounded, knob-shaped, L-shaped, T-shaped, spiral or any other suitable design to enable a better tissue grip for cutting and coagulating to be achieved.
Each umbrella may be made of the same type of spokes, whose surfaces may be similar or a combination of the types described above, or use different types of spokes with similar or different surfaces. The lengths of the spokes of each umbrella may be the same or different. Similarily, the two umbrellas may be similar or different with regards to size, length, number and shape of spokes, including their lengths and surfaces.
The spokes of each umbrella may be connected together by one or more e.g. up to five webs, chains or other more or less flexible connectors.
The outer diameter of the collapsed umbrella is preferably from 1.5mm to 10mm, most preferably 1.5mm to 2.8mm for use with the fibreoptic flexible scopes. The diameter of umbrella when opened up is generally from 10mm to 40mm.
All the spokes within each umbrella can be arranged to deliver electrocoagulating and cutting diathermy currents.
Desirable each umbrella is individually and separately operable by remote control means built into the handle or attached to it. The device is delivered to the site of blockage under direct vision and with both umbrellas in the closed collapsed shape. The tip is placed in direct contact with the lesion and the current is switched on. The tip is advanced into the lesion; then the distal umbrella is slightly opened while the cutting current is switched on to enable the spokes to cut into the lesion; and the device is next rotated to core out some of the lesion. It is desirable that the whole coring out procedure be carried out strictly under direct vision. Thus, the tip of the device should not be pushed too much into the lesion at any one time, nor should the radially outward coring out be too generous. Sufficient coring out should desiarably though be carried out to enable correct guidance of the tip more deeply into the lesion as required. When gas begins to escape indicating the creation of a tunnel through the blockage, the tip is pushed beyond the lesion to enable the distal umbrella to be opened up beyond the lesion, then the device is withdrawn with the cutting current still on to core out more of the lesion. The two umbrellas may be simultaneously or successively used to effect the most desirable coring out of the lesion which creates sufficient passageway that unblocks the rectum or rectosigmoid region. Since the umbrellas will cut the lesion or tumour electrically when opened up and will cut off the growth electrically when rotated around the central longitudinal axis of the device, a combination of forward and backward movements will enhance the electro cutting procedure aimed at achieving the best tunnelling effect. Bleeding points can be secured by electrocoagulation using the tip and/or the spokes of either or both umbrellas of the device. The procedure can be repeated several times until the obstruction is satisfactorily removed. With the two umbrellas provided, it is possible to achieve a high degree of control and selectivity in the extent and position (axially) of radial cutting carried out by using one or other or both with varying degrees of opening e.g. in order to improve vision before further advancing the device into the tissue.
The principles of surgical diathermy are well known in the art and further information is available from standard reference books such as "Encyclopedia of Medical Devices and Instrumentation" published by John Wiley & Sons, New York etc (1988) and other sources, and accordingly need not be described herein in detail.
Briefly diathermy operates by producing an alternating current with wavelengths generally in the radio frequency range. This current passes through the patient's tissues from the active electrode, which may be of various shapes,to the indifferent or dispersive electrode, which is usually a metal or foil plate approximately 15 X 15cm in size. As this current passes through the tissues there is a heating effect beneath each electrode. The indifferent electrode has a large contact area and therefore heating is reduced to a minimum and is dissipated rapidly. The active electrode being small will concentrate heat in the tissues adjacent to it. The current intensity determines whether a coagulating, fulguration or electro- sectioning is produced.
The circuit of the diathermy machine being generally similar to that of a simple radio transmitter will generally oscillate at a frequency between 400kHz
(Kilocycles) and 3MHz (megacycles) . Oscillators used in earlier diathermy machines incorporating the standard spark - gap principle which provide a frequency of around 500kHz may be used. This would provide excellent coagulation but would cut only by increasing the intensity to a high - power output. Also, valve oscillators of a frequency range of up to 3MHz may be used. This can be in the form of two circuits: with a cutting circuit operated by a valve oscillator and the coagulating circuit operated by a spark-gap oscillator. Diathermy generators of power outputs up to 1 kW may conveniently be employed. The use of transistors as oscillators rather than valves is more advantageous.
The quality of coagulation or cutting generally depends on the wave form presented by the diathermy machine, with a smooth sine wave giving the desired cutting while an interrupted burst of current provides the desired coagulation depending on the frequency of these bursts and the length of the gap between each burst. The spark-gap machine gives bursts of damped oscillation of a frequency of approximately 10kHz. When this interuption of current is superimposed on the sine wave oscillation, the coagulation quality is comparable to that of the spark-gap machine. In order to provide an adequate intensity of current the amplitude of each wave should be increased in portion to the length of each burst of current. Thus the doubled circuit may be dispensed with.
Blending the current may be provided by a twin-circuit diathermy where the blender switch brings both circ ..ts into action at the same time with the result that the active electrode produces a cutting effect as well as a coagulating effect as it passes through the tissues. Conversely, a solid state transistorised diathermy machine can be used to provide a blended current from a single circuit by taking the setting halfway between the pure sine wave for cutting and repeated short bursts for coagulation. This provides the advantage of subjecting the patient to only the normal power output of a single circuit. Thus electro-sectioning can be provided by cutting with a valve or transistorised oscillator to ensure minimal surrounding tissue damage or cutting with a blended current if moderate degrees of surrounding coagulation is desirable.
The diathermy machine should normally be earthed to the floor to avoid build up of electrical potential which could discharge in the form of a spark of static electricity. It may be advantageous to monitor the contact of the plate electrode to patient by measuring the potential difference between the in; z and output leads.
The overall power output of the diathermy machine is preferably restricted to from 400 to 500 kW.
The diathermy generator may conveniently be provided by valve oscillating machines, double - circuit spark and valve machines, transistorised solid state diathermies and spark-gap generators.
A foot pedal switch or finger switch may be used to activate the diathermy set, i.e. activating the operating electrode to start the diathermy.
To ensure that the plate is in electrical continuity with the diathermy generator, its cable is preferably designed to have an internal circuit so that if any point between the plate and the diathermy machine is disconnected then an alarm will sound which should also inactivate the circuit of the machine. This may not be necessary with earth-free circuits since the diathermy will be non-operated when the patient is not in contact with the indifferent electrode. Thus, earth-free circuits may also be used for the purposes of the present invention.
The electric connections to the diathermy machine may be placed on any part of the handle. The active electrode socket may be designed in any convenient way to enable the current to flow from the diathermy machine to the catheter tip and both umbrellas. This socket transmits the electric current from the machine directly to the tunnelling device. It may be flush flat with the handle surface or project above it. The active electrode may be plugged in, screwed in, clipped-on or fitted into the socket in any convenient way through one or more points of contact. The handle may have a finger switch to activate the diathermy set. Conversely this may be provided by a foot pedal. The indifferent electrode plate is preferably stuck, strapped or attached in any way onto the patients lower limb, but other sites may also be used.
After the rigid or flexible scope has been introduced and the lesion or tumour assessed with or without biopsy, the tunnelling device is introduced into the rectum or rectosigmoid region and placed in direct contact with the lesion or tumour. The active electrode is connected to the device then the diathermy machine is switched on. The coagulating and cutting currents are generally set in the range from 20 to 90 A, preferably 30 to 60 A. During use the diathermy machine makes a noise which can be clearly heard to indicate it is working and the current is flowing. The coagulating and cutting currents are used as already described. Repeated sessions of tunnelling may be necessary to achieve the desired coring and tunnelling.
It will be understood that various modifications may be made to the above described embodiment without departing from the broadest scope on the present invention. Thus for example a wide variety of remote control operations handle mechanisms may be used including: systems with first and second relatively displacable finger rings or other finger engagement formations which may simply be relatively displacable longitudinally of the device, so as to provide a more or less direct longitudinal compression of the basket resulting in radial expansion, or may be relatively displacable in other dimensions e.g. by compressing or pulling laterally towards each other, conveniently against a return force exerted by resilient biasing means, spaced apart finger engagement portions and use one or more of links, levers, gears and other well known mechanisms for converting relative displacement into a suitable form for transmission to the basket members. In addition hydraulic circuit means and/or electromechanical device may be used for transmitting required control movements to the basket in generally known maner. Conveniently the diathermic cutting and coagulating power supply control means are also provided on the handle means but this is not essential and they may be formed and arranged so as to be operable remotely from the handle means e.g. via a foot operated interface.

Claims

1. A diathermy tunnelling umbrella device suitable for use via the biopsy channel of an endoscope or through a proctoscope or a rigid sigmoidoscope and having remotely operable fr.rst and second opposed collapsible umbrella means with a diathermic distal end cutting and coagulating tip, a plurality of spaced apart diathermic cutting and coagulating spokes of the first umbrella means extending rearwardly from said tip towards the
10 second umbrella means which has a plurality of spaced apart diathermic cutting and coagulating spokes extending forwardly towards said first umbrella means, whereby in use the device tip is advanced by diathermic cutting therewith into a growth with the umbrella means
15 in substantially collaps d condition, at least one of said umbrella means is opened out by diathermic cutting of the spokes thereof generally radially outwardly into the growth, and the umbrella means manipulated by rotation and/or axially to and fro movements for further
20 diathermic cutting into said growth.
2. A device according to claim 1 wherein said spokes of each said umbrella means are at connected one end to a central axial support and are supported remote from said " end by link lever means for .1 and arranged for holding said spokes in radially retracted and in radially extended positions.
3. A device according to claim 2 wherein said link
30 lever means of each umbrella means are coupled together via a respective annular member disposed around said central axial support and axially displacable therelong.
4. A device according to claim 3 wherin an elongate 5 tube extends around the central axial support between the umbrella means and a remote handle means provided with respective control means for said first and second unbrella means.
5. A device according to claim 4 wherein said control means are displacable relative to the main body of said handle means and connected to respective ones of said annular members.
6. A device according to any one of claim 1 to 5 wherein said spokes provided with cutting edges.
7. A device according to any one of calims 1 to 6 wherein said spokes are formed and arranged for positively engaging tumour tissue.
8. A device according to any one of claims 1 to 8 wherein each said umbrella means has an elongate Bowden -cable type control means formed and arranged for remotely expanding said umbrella means.
9. A device according to any onme of claims 1 to 8 which device includes a diathermy electrical power supply.
ιo. A device according to claim 1 for use in tunnelling through large bowel obstructions.
11. A method of tunnelling through large bowel obstructions comprising the steps of: providing a diathermy tunnelling umbrella device according to claim 9; advancing the tip into said obstruction with diathermic cutting; radially expanding at least one said umbrella means with radial diathermic cutting of the spokes into said obstruction; and rotating the expanded umbrella means with annular diathermic cutting of the spokes into said obstruction.
PCT/GB1994/001537 1993-07-15 1994-07-15 Rectal and rectosigmoid cancer tunnelling umbrella WO1995002371A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU71910/94A AU7191094A (en) 1993-07-15 1994-07-15 Rectal and rectosigmoid cancer tunnelling umbrella

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9314641.3 1993-07-15
GB939314641A GB9314641D0 (en) 1993-07-15 1993-07-15 Tunnelling umbrella

Publications (2)

Publication Number Publication Date
WO1995002371A2 true WO1995002371A2 (en) 1995-01-26
WO1995002371A3 WO1995002371A3 (en) 1995-03-09

Family

ID=10738864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1994/001537 WO1995002371A2 (en) 1993-07-15 1994-07-15 Rectal and rectosigmoid cancer tunnelling umbrella

Country Status (3)

Country Link
AU (1) AU7191094A (en)
GB (1) GB9314641D0 (en)
WO (1) WO1995002371A2 (en)

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044506A1 (en) * 1998-03-03 1999-09-10 Senorx, Inc. Breast biopsy system and method
US6277083B1 (en) 1999-12-27 2001-08-21 Neothermia Corporation Minimally invasive intact recovery of tissue
US6287304B1 (en) 1999-10-15 2001-09-11 Neothermia Corporation Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes
US6344026B1 (en) 1998-04-08 2002-02-05 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US6454727B1 (en) 1998-03-03 2002-09-24 Senorx, Inc. Tissue acquisition system and method of use
US6471659B2 (en) 1999-12-27 2002-10-29 Neothermia Corporation Minimally invasive intact recovery of tissue
US6514248B1 (en) 1999-10-15 2003-02-04 Neothermia Corporation Accurate cutting about and into tissue volumes with electrosurgically deployed electrodes
US6517498B1 (en) 1998-03-03 2003-02-11 Senorx, Inc. Apparatus and method for tissue capture
US6540693B2 (en) 1998-03-03 2003-04-01 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US6602251B2 (en) 1998-12-08 2003-08-05 Vascular Control Systems, Inc. Device and methods for occlusion of the uterine artieries
US6635065B2 (en) 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6689071B2 (en) 1998-03-03 2004-02-10 Senorx, Inc. Electrosurgical biopsy device and method
US6764495B2 (en) 1998-09-03 2004-07-20 Rubicor Medical, Inc. Excisional biopsy devices and methods
EP1455669A2 (en) * 2001-11-13 2004-09-15 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US6863676B2 (en) 1998-09-03 2005-03-08 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6905506B2 (en) 2001-03-28 2005-06-14 Vascular Control Systems, Inc. Multi-axial uterine artery identification, characterization, and occlusion pivoting devices and methods
US6936014B2 (en) 2002-10-16 2005-08-30 Rubicor Medical, Inc. Devices and methods for performing procedures on a breast
US7029451B2 (en) 2002-11-06 2006-04-18 Rubicor Medical, Inc. Excisional devices having selective cutting and atraumatic configurations and methods of using same
US7044956B2 (en) 2002-07-03 2006-05-16 Rubicor Medical, Inc. Methods and devices for cutting and collecting soft tissue
US7122011B2 (en) 2003-06-18 2006-10-17 Rubicor Medical, Inc. Methods and devices for cutting and collecting soft tissue
US7198626B2 (en) 2000-12-07 2007-04-03 Rubicor Medical, Inc. Methods and devices for radiofrequency electrosurgery
US7207996B2 (en) 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US7981051B2 (en) 2005-08-05 2011-07-19 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
WO2012010910A1 (en) * 2010-07-23 2012-01-26 The University Of Leeds Surgical retraction device and procedure
US8137346B2 (en) 1998-09-01 2012-03-20 Senorx, Inc. Electrosurgical lesion location device
US8282573B2 (en) 2003-02-24 2012-10-09 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US8419727B2 (en) 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8870867B2 (en) 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
US8888770B2 (en) 2005-05-12 2014-11-18 Aesculap Ag Apparatus for tissue cauterization
US8915864B2 (en) 2005-08-05 2014-12-23 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US9044215B2 (en) 2003-02-24 2015-06-02 Senorx, Inc. Biopsy device with selectable tissue receiving aperature orientation and site illumination
US9095325B2 (en) 2005-05-23 2015-08-04 Senorx, Inc. Tissue cutting member for a biopsy device
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
US9510809B2 (en) 1999-01-27 2016-12-06 Senorx, Inc. Tissue specimen isolating and damaging device and method
US9872724B2 (en) 2012-09-26 2018-01-23 Aesculap Ag Apparatus for tissue cutting and sealing
US9918778B2 (en) 2006-05-02 2018-03-20 Aesculap Ag Laparoscopic radiofrequency surgical device
US10004555B2 (en) 2011-06-28 2018-06-26 Aesculap Ag Electrosurgical tissue dissecting device
US10105125B2 (en) 2004-12-16 2018-10-23 Senorx, Inc. Biopsy device with aperture orientation and improved tip
WO2019034190A1 (en) * 2017-08-16 2019-02-21 Olympus Winter & Ibe Gmbh Surgical instrument for a flexible endoscope
US10314642B2 (en) 2005-05-12 2019-06-11 Aesculap Ag Electrocautery method and apparatus
US10835312B2 (en) 2013-04-16 2020-11-17 Transmed7, Llc Methods, devices and therapeutic platform for automated, selectable, soft tissue resection
CN117338496A (en) * 2023-12-04 2024-01-05 北京久事神康医疗科技有限公司 Drug stent conveying device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408592B2 (en) 2003-12-23 2016-08-09 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US9339323B2 (en) 2005-05-12 2016-05-17 Aesculap Ag Electrocautery method and apparatus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
EP0189329A2 (en) * 1985-01-25 1986-07-30 Robert E. Fischell A tunneling catheter system for transluminal arterial angioplasty
US4976711A (en) * 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5154724A (en) * 1990-05-14 1992-10-13 Andrews Winston A Atherectomy catheter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
EP0189329A2 (en) * 1985-01-25 1986-07-30 Robert E. Fischell A tunneling catheter system for transluminal arterial angioplasty
US4976711A (en) * 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5154724A (en) * 1990-05-14 1992-10-13 Andrews Winston A Atherectomy catheter

Cited By (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044506A1 (en) * 1998-03-03 1999-09-10 Senorx, Inc. Breast biopsy system and method
US6331166B1 (en) 1998-03-03 2001-12-18 Senorx, Inc. Breast biopsy system and method
US6699206B2 (en) 1998-03-03 2004-03-02 Senorx, Inc. Breast biopsy system and methods
US6712775B2 (en) 1998-03-03 2004-03-30 Senorx, Inc. Tissue acquisition system and method of use
EP2033580A1 (en) * 1998-03-03 2009-03-11 Senorx, Inc. Breast biopsy system
US6454727B1 (en) 1998-03-03 2002-09-24 Senorx, Inc. Tissue acquisition system and method of use
US7322939B2 (en) 1998-03-03 2008-01-29 Senorx, Inc. Breast biopsy system and methods
US7229418B2 (en) 1998-03-03 2007-06-12 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US7625347B2 (en) 1998-03-03 2009-12-01 Senorx, Inc. Electrosurgical biopsy device and method
US6517498B1 (en) 1998-03-03 2003-02-11 Senorx, Inc. Apparatus and method for tissue capture
US6540693B2 (en) 1998-03-03 2003-04-01 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
EP2025292A1 (en) * 1998-03-03 2009-02-18 Senorx, Inc. Breast biopsy system
US8152737B2 (en) 1998-03-03 2012-04-10 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US6689071B2 (en) 1998-03-03 2004-02-10 Senorx, Inc. Electrosurgical biopsy device and method
US7488295B2 (en) 1998-04-08 2009-02-10 Senorx, Inc. Tissue acquisition system and method of use
US6344026B1 (en) 1998-04-08 2002-02-05 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US6508773B2 (en) 1998-04-08 2003-01-21 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US9216012B2 (en) 1998-09-01 2015-12-22 Senorx, Inc Methods and apparatus for securing medical instruments to desired locations in a patient's body
US8137346B2 (en) 1998-09-01 2012-03-20 Senorx, Inc. Electrosurgical lesion location device
US6764495B2 (en) 1998-09-03 2004-07-20 Rubicor Medical, Inc. Excisional biopsy devices and methods
US7303531B2 (en) 1998-09-03 2007-12-04 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6849080B2 (en) 1998-09-03 2005-02-01 Rubicon Medical, Inc. Excisional biopsy device and methods
US6863676B2 (en) 1998-09-03 2005-03-08 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6602251B2 (en) 1998-12-08 2003-08-05 Vascular Control Systems, Inc. Device and methods for occlusion of the uterine artieries
US6764488B1 (en) 1998-12-08 2004-07-20 Vascular Control Systems, Inc. Devices and methods for occlusion of the uterine arteries
US9510809B2 (en) 1999-01-27 2016-12-06 Senorx, Inc. Tissue specimen isolating and damaging device and method
US6287304B1 (en) 1999-10-15 2001-09-11 Neothermia Corporation Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes
US6514248B1 (en) 1999-10-15 2003-02-04 Neothermia Corporation Accurate cutting about and into tissue volumes with electrosurgically deployed electrodes
US6277083B1 (en) 1999-12-27 2001-08-21 Neothermia Corporation Minimally invasive intact recovery of tissue
US6471659B2 (en) 1999-12-27 2002-10-29 Neothermia Corporation Minimally invasive intact recovery of tissue
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6635065B2 (en) 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US7198626B2 (en) 2000-12-07 2007-04-03 Rubicor Medical, Inc. Methods and devices for radiofrequency electrosurgery
US6905506B2 (en) 2001-03-28 2005-06-14 Vascular Control Systems, Inc. Multi-axial uterine artery identification, characterization, and occlusion pivoting devices and methods
EP1455669A4 (en) * 2001-11-13 2010-03-17 Mayo Foundation Tissue ablation device and methods of using
EP1455669A2 (en) * 2001-11-13 2004-09-15 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US7207996B2 (en) 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7044956B2 (en) 2002-07-03 2006-05-16 Rubicor Medical, Inc. Methods and devices for cutting and collecting soft tissue
US8066727B2 (en) 2002-07-03 2011-11-29 Rubicor Medical Llc Methods and devices for cutting and collecting soft tissue
US7438693B2 (en) 2002-10-16 2008-10-21 Rubicor Medical, Inc. Devices and methods for performing procedures on a breast
US6936014B2 (en) 2002-10-16 2005-08-30 Rubicor Medical, Inc. Devices and methods for performing procedures on a breast
US7029451B2 (en) 2002-11-06 2006-04-18 Rubicor Medical, Inc. Excisional devices having selective cutting and atraumatic configurations and methods of using same
US9044215B2 (en) 2003-02-24 2015-06-02 Senorx, Inc. Biopsy device with selectable tissue receiving aperature orientation and site illumination
US10231715B2 (en) 2003-02-24 2019-03-19 Senorx, Inc. Biopsy device with inner cutting member
US8282573B2 (en) 2003-02-24 2012-10-09 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US9204866B2 (en) 2003-02-24 2015-12-08 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US10335127B2 (en) 2003-02-24 2019-07-02 Senorx, Inc. Biopsy device with selectable tissue receiving aperature orientation and site illumination
US10172595B2 (en) 2003-02-24 2019-01-08 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US11589849B2 (en) 2003-02-24 2023-02-28 Senorx, Inc. Biopsy device with selectable tissue receiving aperature orientation and site illumination
US11534147B2 (en) 2003-02-24 2022-12-27 Senorx, Inc. Biopsy device with a removable sample recieving cartridge
US7122011B2 (en) 2003-06-18 2006-10-17 Rubicor Medical, Inc. Methods and devices for cutting and collecting soft tissue
US7615013B2 (en) 2003-06-18 2009-11-10 Rubicor Medical, Inc. Methods and devices for cutting and collecting soft tissue
US10105125B2 (en) 2004-12-16 2018-10-23 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US11246574B2 (en) 2004-12-16 2022-02-15 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US8888770B2 (en) 2005-05-12 2014-11-18 Aesculap Ag Apparatus for tissue cauterization
US10314642B2 (en) 2005-05-12 2019-06-11 Aesculap Ag Electrocautery method and apparatus
US9750487B2 (en) 2005-05-23 2017-09-05 Senorx, Inc. Tissue cutting member for a biopsy device
US11426149B2 (en) 2005-05-23 2022-08-30 SenoRx., Inc. Tissue cutting member for a biopsy device
US9095325B2 (en) 2005-05-23 2015-08-04 Senorx, Inc. Tissue cutting member for a biopsy device
US10478161B2 (en) 2005-05-23 2019-11-19 Senorx, Inc. Tissue cutting member for a biopsy device
US8915864B2 (en) 2005-08-05 2014-12-23 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US7981051B2 (en) 2005-08-05 2011-07-19 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US10064609B2 (en) 2005-08-05 2018-09-04 Senorx, Inc. Method of collecting one or more tissue specimens
US10874381B2 (en) 2005-08-05 2020-12-29 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US9918778B2 (en) 2006-05-02 2018-03-20 Aesculap Ag Laparoscopic radiofrequency surgical device
US11058478B2 (en) 2006-05-02 2021-07-13 Aesculap Ag Laparoscopic radiofrequency surgical device
US8870867B2 (en) 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
US9277962B2 (en) 2010-03-26 2016-03-08 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US10130411B2 (en) 2010-03-26 2018-11-20 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8419727B2 (en) 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
WO2012010910A1 (en) * 2010-07-23 2012-01-26 The University Of Leeds Surgical retraction device and procedure
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
US10004555B2 (en) 2011-06-28 2018-06-26 Aesculap Ag Electrosurgical tissue dissecting device
US9872724B2 (en) 2012-09-26 2018-01-23 Aesculap Ag Apparatus for tissue cutting and sealing
US10835312B2 (en) 2013-04-16 2020-11-17 Transmed7, Llc Methods, devices and therapeutic platform for automated, selectable, soft tissue resection
WO2019034190A1 (en) * 2017-08-16 2019-02-21 Olympus Winter & Ibe Gmbh Surgical instrument for a flexible endoscope
CN117338496A (en) * 2023-12-04 2024-01-05 北京久事神康医疗科技有限公司 Drug stent conveying device
CN117338496B (en) * 2023-12-04 2024-02-09 北京久事神康医疗科技有限公司 Drug stent conveying device

Also Published As

Publication number Publication date
GB9314641D0 (en) 1993-08-25
AU7191094A (en) 1995-02-13
WO1995002371A3 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
WO1995002371A2 (en) Rectal and rectosigmoid cancer tunnelling umbrella
WO1995002370A2 (en) Tunnelling catheter
CA2049146C (en) Ablation catheter
JP3806088B2 (en) Equipment for high frequency electrosurgery
US7147635B2 (en) Bipolar electrosurgical snare
US6827725B2 (en) Surgical instrument
US8251991B2 (en) Anchored RF ablation device for the destruction of tissue masses
US20180125566A1 (en) Anchored rf ablation device for the destruction of tissue masses
JP4515008B2 (en) System and method for treating intestinal and rectal dysfunction
US6190386B1 (en) Electrosurgical forceps with needle electrodes
US7306591B2 (en) Apparatus and methods for treating female urinary incontinence
AU2005244649B2 (en) A surgical instrument
CN101066222B (en) Integrated guidewire needle knife device
US6296639B1 (en) Apparatuses and methods for interstitial tissue removal
EP0562195A1 (en) Monopolar polypectomy snare with coagulation electrode
JP2004532668A (en) Steerable sphincterotomy device and cannula insertion, papillostomy and sphincterotomy method
US20090264910A1 (en) Methods and devices for dissecting tissue
EP3785654B1 (en) Multifunctional high-frequency electric knife
JPH11511674A (en) Electrode assembly for resectoscope that performs cutting and coagulation simultaneously
WO2005079901A1 (en) Endoscopic multi-lumen devices and related methods of use
JPH07503645A (en) medical probe device
JP2003526460A (en) Operating device that can be detachably fitted to a catheter body for treating a body tissue region
US10342565B2 (en) Surgical system with expandable shield
WO2014153914A1 (en) Integrated bracket imbedding device
CN114269273A (en) Expandable ablation device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): KE MW SD AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE MW SD AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase in:

Ref country code: CA

122 Ep: pct application non-entry in european phase